NIH-funded research R21 grant

Developing advanced materials to improve cancer imaging with PET scans

Official title: Exploring concepts in nanophotonics and metamaterials to create a 'super-scintillator' for time-of-flight positron emission tomography

Funded at Stanford University · NIH-10685592 · Data updated 2026-11-12

This study is testing a new technology that could make PET scans better for spotting cancer and heart disease, helping doctors see important details more clearly so they can provide more accurate diagnoses and treatment plans for patients.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionStanford University
NIH-funded
Lab location1 site (Stanford, United States)
Project startAugust 17, 2022
Project endJune 30, 2025
Funding year2023
Award (this year)$196,750
NIH project number5R21EB033551-02
Project IDNIH-10685592 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing PET scans for cancer or heart disease.

Less likely to help

Patients with conditions that do not require PET imaging or those who are not candidates for radiolabeled contrast agents may not benefit from this research.

What this research studies

This research focuses on enhancing positron emission tomography (PET), a key imaging technique used to diagnose and monitor cancer and heart disease. The team aims to create a novel 'super-scintillator' using metamaterials, which will improve the quality and accuracy of PET images. By injecting a radiolabeled contrast agent into patients, the technology will allow for better visualization of disease biomarkers, leading to more precise diagnosis and treatment planning. The study will explore how advancements in imaging technology can significantly impact patient care.

Why it matters

Potential benefit: If successful, this research could lead to more accurate cancer diagnoses and improved treatment monitoring for patients.

How similar studies have gone: Previous research has shown promising results in enhancing imaging techniques, indicating potential for success with this novel approach.

Where this research is happening

  • Stanford University
    Stanford, United States
    Active

Researchers

  • Principal investigator: Levin, Craig S — Stanford University
  • Study coordinator: Levin, Craig S

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.